Asan Medical Center Myocardial Infarction Registry

Coronary Stenosis Clinical Trial

— Asan-MI  

Official title:

Asan Medical Center Myocardial Infarction Registry

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03412435
• Other study ID #: AMCCV2018-01
• Status: Recruiting
• Start date: April 27, 2018
• Est. completion date: December 31, 2030

Study information

• Verified date: December 2023
• Source: Asan Medical Center
• Contact: Seung-jung Park, MD
• Email: sjpark[@]amc.seoul.kr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study evaluates long-term outcome of patients diagnosed as acute myocardial infarction and treated with medication, coronary artery bypass surgery and percutaneous coronary intervention in Asan medical center, Korea.

Description:

This study will collect 3000 cases retrospectively and 2000 cases prospectively.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 5000
• Est. completion date: December 31, 2030
• Est. primary completion date: December 31, 2025
• Accepts healthy volunteers: No
• Gender: All
• Age group: 19 Years and older

Eligibility

Inclusion Criteria:

• All consecutive acute myocardial infarction patients diagnosed through coronary angiography

Related Conditions & MeSH terms

• Coronary Stenosis
• Infarction
• Myocardial Infarction
• Myocardial Infarction, Acute

Locations

Country	Name	City	State
Korea, Republic of	Asan Medical Center	Seoul

Sponsors (2)

Lead Sponsor	Collaborator
Seung-Jung Park	CardioVascular Research Foundation, Korea

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	A composite event of all-cause death, non-fatal myocardial infarction and repeat revascularization		1 year
Secondary	All cause death		5 year
Secondary	Cardiac death		5 year
Secondary	Myocardial infarction		5 year
Secondary	A composite event of all-cause death and myocardial infarction		5 year
Secondary	A composite event of cardiac death and myocardial infarction		5 year
Secondary	Repeat revascularization		5 year
Secondary	Stent thrombosis	according to Academic Research Consortium (ARC) criteria	5 year
Secondary	Stroke	A stroke or cerebrovascular accident with loss of neurological function caused by an ischemic or hemorrhagic event with residual symptoms at least 24 hours after onset or leading to death.	5 year
Secondary	Procedure success	Successful percutaneous coronary intervention at the intended target lesion with final instant residual stenosis of less than 30% by quantitative coronary angiography (QCA) and no event of death or Q wave myocardial infarction or urgent revascularization during hospitalization.	7 days
Secondary	Surgery success	Successful surgery defines as no event of death or Q wave myocardial infarction or urgent revascularization during hospitalization.	7 days